Pharmacogenomics
Development of a scalable pharmacogenomic clinical decision support service
Fusaro VA, et al. AMIA Summits Transl Sci Proc2013;2013:60
Fusaro VA, et al. AMIA Summits Transl Sci Proc2013;2013:60
Impact of CYP2C19 genetic testing on provider prescribing patterns for antiplatelet therapy after acute coronary syndromes and percutaneous coronary intervention.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vtDSGMI-yEezW7P4xVGYYkjlbjLLdcDfSqDf3al8Q8qcsxBiogiQj8SslVDfzwez2cIM6UbpbkGJDzq1MNEd92BUmj0NVtjfabKOQqWNS3ENvRw7ClRekD=s0-d)
Desai NR, Circ Cardiovasc Qual Outcomes. 2013 Nov 1;6(6):694-9.
Desai NR, Circ Cardiovasc Qual Outcomes. 2013 Nov 1;6(6):694-9.
Integrating pharmacogenetic information and clinical decision support into the electronic health record![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vtDSGMI-yEezW7P4xVGYYkjlbjLLdcDfSqDf3al8Q8qcsxBiogiQj8SslVDfzwez2cIM6UbpbkGJDzq1MNEd92BUmj0NVtjfabKOQqWNS3ENvRw7ClRekD=s0-d)
Goldspiel BR, et al. J Am Med Inform Assoc 2013 Dec
Goldspiel BR, et al. J Am Med Inform Assoc 2013 Dec
Pharmacogenetics and coumarin dosing — recalibrating expectations![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vtDSGMI-yEezW7P4xVGYYkjlbjLLdcDfSqDf3al8Q8qcsxBiogiQj8SslVDfzwez2cIM6UbpbkGJDzq1MNEd92BUmj0NVtjfabKOQqWNS3ENvRw7ClRekD=s0-d)
Zineh I, et al. N Engl J Med 2013; 369:2273-2275 2013 Dec 12
Zineh I, et al. N Engl J Med 2013; 369:2273-2275 2013 Dec 12
Providing pharmacogenomics clinical decision support using whole genome sequencing data as input
Huser V & Cimino JJ AMIA Summits Transl Sci Proc 2013;2013:81
Huser V & Cimino JJ AMIA Summits Transl Sci Proc 2013;2013:81
No hay comentarios:
Publicar un comentario